Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice.

Vázquez-Padrón RI, Moreno-Fierros L, Neri-Bazán L, de la Riva GA, López-Revilla R.

Life Sci. 1999;64(21):1897-912.

PMID:
10353588
3.

Bacillus thuringiensis Cry1Ac protoxin is a potent systemic and mucosal adjuvant.

Vázquez RI, Moreno-Fierros L, Neri-Bazán L, De La Riva GA, López-Revilla R.

Scand J Immunol. 1999 Jun;49(6):578-84.

4.

Intranasal Cry1Ac protoxin is an effective mucosal and systemic carrier and adjuvant of Streptococcus pneumoniae polysaccharides in mice.

Moreno-Fierros L, Ruiz-Medina EJ, Esquivel R, López-Revilla R, Piña-Cruz S.

Scand J Immunol. 2003 Jan;57(1):45-55.

5.

Characterization of the mucosal and systemic immune response induced by Cry1Ac protein from Bacillus thuringiensis HD 73 in mice.

Vázquez-Padrón RI, Moreno-Fierros L, Neri-Bazán L, Martínez-Gil AF, de-la-Riva GA, López-Revilla R.

Braz J Med Biol Res. 2000 Feb;33(2):147-55.

6.

Immunization with Cry1Ac from Bacillus thuringiensis increases intestinal IgG response and induces the expression of FcRn in the intestinal epithelium of adult mice.

Verdin-Terán SL, Vilches-Flores A, Moreno-Fierros L.

Scand J Immunol. 2009 Dec;70(6):596-607. doi: 10.1111/j.1365-3083.2009.02332.x.

7.
9.
10.

[The difficulty of obtaining immunologic responses in mucosae. Use of coadjuvants].

Rodríguez Orozco AR.

Rev Alerg Mex. 2003 Jul-Aug;50(4):161-5. Spanish.

PMID:
14513603
11.

Striking activation of NALT and nasal passages lymphocytes induced by intranasal immunization with Cry1Ac protoxin.

Rodriguez-Monroy MA, Moreno-Fierros L.

Scand J Immunol. 2010 Mar;71(3):159-68. doi: 10.1111/j.1365-3083.2009.02358.x.

12.
13.

Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis.

Rojas-Hernández S, Rodríguez-Monroy MA, López-Revilla R, Reséndiz-Albor AA, Moreno-Fierros L.

Infect Immun. 2004 Aug;72(8):4368-75.

14.

Carrier potential properties of Bacillus thuringiensis Cry1A toxins for a diphtheria toxin epitope.

Guerrero GG, Moreno-Fierros L.

Scand J Immunol. 2007 Dec;66(6):610-8. Epub 2007 Oct 19.

15.

Cry1Ac protoxin from Bacillus thuringiensis sp. kurstaki HD73 binds to surface proteins in the mouse small intestine.

Vázquez-Padrón RI, Gonzáles-Cabrera J, García-Tovar C, Neri-Bazan L, Lopéz-Revilla R, Hernández M, Moreno-Fierro L, de la Riva GA.

Biochem Biophys Res Commun. 2000 Apr 29;271(1):54-8.

PMID:
10777680
16.

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.

Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.

Vaccine. 2003 Mar 7;21(11-12):1165-73.

PMID:
12559794
17.

Adjuvant effects of crystal proteins from a Mexican strain of Bacillus thuringiensis on the mouse humoral response.

Román Calderón ME, Alcocer González JM, Franco Molina MA, Tamez Guerra RS, Rodríguez Padilla C.

Biologicals. 2007 Oct;35(4):271-6. Epub 2007 Apr 3.

PMID:
17408965
20.

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.

Yasuda Y, Isaka M, Taniguchi T, Zhao Y, Matano K, Matsui H, Morokuma K, Maeyama J, Ohkuma K, Goto N, Tochikubo K.

Vaccine. 2003 Jun 20;21(21-22):2954-63.

PMID:
12798639

Supplemental Content

Support Center